References
- Mahler D A, Jones P W. Key outcomes in COPD: exacerbations and dyspnea. Eur Respir Rev 2002; 12: 1–54
- Mahler D A. Dyspnea. Pharmacotherapy of COPD, B R Celli. Marcel Dekker Inc, New York 2003; 145–157
- Fletcher C M, Elmes P C, Wood C H. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959; 1: 257–266
- Mahler D A, Jones P W, Guyatt G H. Clinical measurement of dyspnea. Dyspnea, D A Mahler. Marcel Dekker Inc, New York 1998; 149–198
- Mahler D A, Weinberg D H, Wells C K, Feinstein A R. The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85: 751–758, [PUBMED], [INFOTRIEVE]
- Mahler D A, Wells C K. Evaluation of clinical methods for rating dyspnea. Chest 1988; 93: 580–586, [PUBMED], [INFOTRIEVE]
- Mahler D A, Harver A. A factor analysis of dyspnea ratings, respiratory muscle strength and lung function in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 145: 467–470, [PUBMED], [INFOTRIEVE]
- Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 1185–1189, [PUBMED], [INFOTRIEVE], [CSA]
- Witek T J, Jr, Mahler D A. Meaningful effect size and patterns of response of the transition dyspnea index. J Clin Epidemiol 2003; 56: 248–255, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Witek T J, Jr, Mahler D A. Minimal important difference of the transition dyspnea index in a multi‐national clinical trial. Eur Respir J 2003; 21: 267–272, [PUBMED], [INFOTRIEVE]
- Mahler D A, Matthay R A, Snyder P E, Wells C K, Loke J. Sustained‐release theophyline reduces dyspnea in nonreversible obstructive airway disease. Am Rev Respir Dis 1985; 131: 22–25, [PUBMED], [INFOTRIEVE]
- Casaburi R, Mahler D A, Jones P W, Wanner A, SanPedro G, ZuWallack R L, Menjoge S S, Serby C W, Witek T, Jr. A long‐term evaluation of once‐daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002; 19: 217–224, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Mahler D A, Wire P, Horstman D, Chang C N, Yates J, Fischer T, Shah T. Effectiveness of fluticasone propionate and salmeterol combination delivered via the diskus device in the treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 1084–1091, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Reardon J, Awad E, Normandin E, Vale F, Clark B, ZuWallack R L. The effect of comprehensive outpatient pulmonary rehabilitation on dyspnea. Chest 1994; 105: 1046–1052, [PUBMED], [INFOTRIEVE]
- Ries A L, Kaplan R M, Myers R, Prewitt L M. Maintenance after pulmonary rehabilitation in chronic lung disease. Am J Respir Crit Care Med 2003; 167: 880–888, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Foglio K, Bianchi L, Bruletti G, Battista L, Pagani M, Ambrosino N. Long‐term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction. Eur Respir J 1999; 13: 125–232, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Harver A, Mahler D A, Daubenspeck J A. Targeted inspiratory muscle training improves respiratory muscle function and reduces dyspnea in patients with chronic obstructive pulmonary disease. Ann Intern Med 1989; 111: 117–124, [PUBMED], [INFOTRIEVE]
- Lisboa C, Munoz V, Beroiza T, Leiva A, Cruz E. Inspiratory muscle training in chronic airflow limitation: comparison of two different training loads with a threshold device. Eur Respir J 1994; 7: 1266–1274, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Martinez F J, Montez de Oca M, Whyte R I, Stetz J, Gay S E, Celli B R. Lung‐volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. Am J Respir Crit Care Med 1997; 155: 1984–1990, [PUBMED], [INFOTRIEVE], [CSA]
- American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: S77–S120, [CSA]
- Mahler D A, Ward J, Baird J C. Validity of self‐administered computerized (SAC) Baseline Dyspnea Index (BDI). Am J Respir Crit Care Med 2003; 167: A312, (Abstract)
- Crapo R O, Morris A H, Gardner R M. Reference spirometry values using techniques and equipment that meets ATS recommendations. Am Rev Respir Dis 1981; 123: 659–664, [PUBMED], [INFOTRIEVE]
- Williams J EA, Singh S J, Sewell L, Guyatt G H, Morgan M DL. Development of a self‐reported chronic respiratory questionnaire (CRQ‐SR). Thorax 2001; 56: 954–959, [PUBMED], [INFOTRIEVE], [CROSSREF]